• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Allergy Therapeutics PLC

+ Add to Watchlist


0.309 EUR 0.003 0.98%

As of 02:08:35 ET on 01/26/2015.

Snapshot for Allergy Therapeutics PLC (HHU)

Open: 0.309 Day's Range: 0.309 - 0.309 Volume: 0
Previous Close: 0.306 52wk Range: 0.090 - 0.361 1-Yr Rtn: +239.56%

Stock Chart for HHU

No chart data available.
  • HHU:GR 0.309
  • 1M
  • 1Y
Interactive HHU Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HHU

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) 115.5907
Relative P/E vs. DAX -
Earnings Per Share (GBP) (ttm) -
Est. EPS (GBP) (06/2015) 0.0020
Est. PEG Ratio -
Market Cap (M EUR) 126.71
Shares Outstanding (M) 410.06
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/02/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HHU

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for HHU

Allergy Therapeutics Plc is a specialty pharmaceutical company that develops medical drugs for the treatment and prevention of allergies. The Company sells and distributes vaccine products ranging from general seasonal pollen allergy vaccinations for common allergies to patient-specific short run batches for less common allergens.

Manuel LlobetChief Executive OfficerIan PostlethwaiteFinance Director/Secretary
More Company Profile & Key Executives for HHU

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil